ASH 2022 Conference Coverage
Luspatercept for Treatment of LR-MDS: Real World Data Replicates MEDALIST Study Results and Confirms Activity Among HMAs and Lenalidomide Treated Pts
By
ASH 2022 Conference Coverage
FEATURING
Rami Komrokji
By
ASH 2022 Conference Coverage
FEATURING
Rami Komrokji
Login to view comments.
Click here to Login
